Illumina Inc

+1.59 (+0.79%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)32.24B
Current PEN/A
Forward PE 152.18
2yr Forward PE 65.57
See more stats
Estimates Current Quarter
Revenue$1.17 Billion
Adjusted EPS$0.03
See more estimates
10-Day MA$203.02
50-Day MA$212.14
200-Day MA$210.01
See more pivots

Illumina Inc Stock, NASDAQ:ILMN

5200 Illumina Way, San Diego, California 92122
United States of America
Phone: +1.858.202.4500
Number of Employees: 11500


Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.